Jennifer Elisseeff

Jennifer Elisseeff


Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
OJOk Hee Jeon
Ok Hee Jeon
CKChaekyu Kim
Chaekyu Kim
RLRemi-Martin Laberge
Remi-Martin Laberge
MDMarco Demaria
Marco Demaria
SRSona Rathod
Sona Rathod
JEJennifer Elisseeff
Jennifer Elisseeff

15 April 2007 in Nature Materials
Verified
Journal Article
Closed access
PDF file
DWDong-An Wang
Dong-An Wang
SVShyni Varghese
Shyni Varghese
BSBlanka Sharma
Blanka Sharma
ISIossif Strehin
Iossif Strehin
SFSara Fermanian
Sara Fermanian
JEJennifer Elisseeff
Jennifer Elisseeff

15 April 2016 in Science
Verified
Journal Article
Closed access
PDF file
KSKaitlyn Sadtler
Kaitlyn Sadtler
KEKenneth Estrellas
Kenneth Estrellas
BABrian W. Allen
Brian W. Allen
MWMatthew T. Wolf
Matthew T. Wolf
HFHongni Fan
Hongni Fan
JEJennifer Elisseeff
Jennifer Elisseeff
Engineering a healing immune response: Infections, surgeries, and trauma can all cause major tissue damage. Biomaterial scaffolds, which help to guide regenerating tissue, are an exciting emerging therapeutic strategy to promote tissue repair. Sadtler et al. tested how biomaterial scaffolds interact with the immune system in damaged tissue to promote repair (see the Perspective by Badylak). Scaffolds derived from cardiac muscle and bone extracellular matrix components trigger a tissue-reparative T cell immune response in mice with injured muscles. Science , this issue p. 366 ; see also p. 298

14 December 2016 in Nature
Verified
Journal Article
Closed access
PDF file
JGJordan J. Green
Jordan J. Green
JEJennifer Elisseeff
Jennifer Elisseeff

2 April 2018 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
OJOk Hee Jeon
Ok Hee Jeon
NDNathaniel David
Nathaniel David
JCJudith Campisi
Judith Campisi
JEJennifer Elisseeff
Jennifer Elisseeff
Senescent cells (SnCs) are associated with age-related pathologies. Osteoarthritis is a chronic disease characterized by pain, loss of cartilage, and joint inflammation, and its incidence increases with age. For years, the presence of SnCs in cartilage isolated from patients undergoing total knee artificial implants has been noted, but these cells' relevance to disease was unclear. In this Review, we summarize current knowledge of SnCs in the multiple tissues that constitute the articular joint. New evidence for the causative role of SnCs in the development of posttraumatic and age-related arthritis is reviewed along with the therapeutic benefit of SnC clearance. As part of their senescence-associated secretory phenotype, SnCs secrete cytokines that impact the immune system and its response to joint tissue trauma. We present concepts of the immune response to tissue trauma as well as the interactions with SnCs and the local tissue environment. Finally, we discuss therapeutic implications of targeting SnCs in treating osteoarthritis.

1 May 2017 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
LCLiam Chung
Liam Chung
DJDavid Maestas Jr
David Maestas Jr
FHFranck Housseau
Franck Housseau
JEJennifer Elisseeff
Jennifer Elisseeff